ArticleBMC oral health2025
Factors influencing recurrence after in-hospital treatment of odontogenic-related oromaxillofacial infections: a single-centre experience.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Procalcitonin as a predictor of length of stay in patients with odontogenic infections.Oral and maxillofacial surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEvidence regarding specific factors influencing recurrence after treatment of oromaxillofacial infections is limited. This study aimed to evaluate the incidence and identify predictors of recurrence following in-hospital treatment. A secondary aim was to analyze associations between patient- and procedure-specific variables, treatment outcomes, and hospital length of stay (LOS), and to identify high-risk patients.
methodsIn this retrospective, single-center study, patients with odontogenic-related oromaxillofacial infections treated surgically or conservatively over a 4-year period were included. Demographic, clinical, radiological, and treatment data were analyzed. Multivariable analyses were performed to identify predictors of recurrence and LOS.
resultsA total of 939 patients (mean age 44.66 ± 22.95 years) met the inclusion criteria. The recurrence rate was 5.01%, and the mean LOS was 3.55 ± 2.47 days. Increased age and BMI, mandibular infections, infections post-extraction or post-augmentation, clinical symptoms at admission (restricted mouth opening, dysphagia, non-palpable mandibular margin), elevated inflammatory markers (CRP, leukocytes, neutrophils, procalcitonin), and cervical drainage were significantly associated with higher recurrence risk and increased LOS (p < 0.05). A postoperative ICU stay increased the recurrence risk 9.13-fold.
conclusionsWithin the limitations of this study, the results suggest that older age, higher BMI, mandibular involvement, post-extraction or post-augmentation infections, specific clinical symptoms at admission (restricted mouth opening, dysphagia, non-palpable mandibular margin), elevated inflammatory markers, cervical drainage approaches, and stay in ICU are associated with both a higher risk of infection recurrence and increased hospital stay. Multiple bacterial strains and no continuous antibiotic therapy after discharge also indicated a higher risk of recurrence, while surgery under intubation anesthesia was linked to an increased length of stay only. These factors should be considered early in treatment planning to optimize outcomes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.